Does RUXOLITINIB Cause Multiple organ dysfunction syndrome? 305 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Multiple organ dysfunction syndrome have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.5% of all adverse event reports for RUXOLITINIB.
305
Reports of Multiple organ dysfunction syndrome with RUXOLITINIB
0.5%
of all RUXOLITINIB reports
273
Deaths
174
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From RUXOLITINIB?
Of the 305 reports, 273 (89.5%) resulted in death, 174 (57.0%) required hospitalization, and 62 (20.3%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which RUXOLITINIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE